BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30946937)

  • 21. Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach.
    Arai T; Sakurai U; Sawabe M; Honma N; Aida J; Ushio Y; Kanazawa N; Kuroiwa K; Takubo K
    Gastric Cancer; 2013 Oct; 16(4):505-12. PubMed ID: 23274922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
    Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
    Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
    Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
    Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dedifferentiation-like tubular and solid carcinoma of the stomach shows phenotypic divergence and association with deficient SWI/SNF complex.
    Huang SC; Chen KH; Ng KF; Lin IC; Chao YC; Yeh TS; Chuang HC; Chen TC
    Virchows Arch; 2022 Apr; 480(4):771-781. PubMed ID: 35122125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability.
    Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G
    J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer.
    Haron NH; Mohamad Hanif EA; Abdul Manaf MR; Yaakub JA; Harun R; Mohamed R; Mohamed Rose I
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):509-517. PubMed ID: 30803214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
    Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
    J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular subtype switching in early-stage gastric cancers with multiple occurrences.
    Takaoka S; Hirotsu Y; Ohyama H; Mochizuki H; Amemiya K; Oyama T; Ashizawa H; Yoshimura D; Nakagomi K; Hosoda K; Suzuki Y; Kojima Y; Omata M
    J Gastroenterol; 2019 Aug; 54(8):674-686. PubMed ID: 30666417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histogenesis of hepatoid adenocarcinoma of the stomach: molecular evidence of identical origin with coexistent tubular adenocarcinoma.
    Akiyama S; Tamura G; Endoh Y; Fukushima N; Ichihara Y; Aizawa K; Kawata S; Motoyama T
    Int J Cancer; 2003 Sep; 106(4):510-515. PubMed ID: 12845645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Integrative Morphomolecular Classification System of Gastric Carcinoma With Distinct Clinical Outcomes.
    Tsai JH; Jeng YM; Chen KH; Lee CH; Yuan CT; Liau JY
    Am J Surg Pathol; 2020 Aug; 44(8):1017-1030. PubMed ID: 32568823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
    Yoon JY; Brezden-Masley C; Streutker CJ
    BMC Cancer; 2020 Sep; 20(1):860. PubMed ID: 32894084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
    Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
    J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
    Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y
    J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Colorectal oncogenesis].
    Laurent-Puig P; Agostini J; Maley K
    Bull Cancer; 2010 Nov; 97(11):1311-21. PubMed ID: 21115420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer.
    Kohlruss M; Krenauer M; Grosser B; Pfarr N; Jesinghaus M; Slotta-Huspenina J; Novotny A; Hapfelmeier A; Schmidt T; Steiger K; Gaida MM; Reiche M; Bauer L; Ott K; Weichert W; Keller G
    Br J Cancer; 2021 Dec; 125(12):1621-1631. PubMed ID: 34671125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.
    Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F
    Pathol Oncol Res; 2019 Jan; 25(1):333-340. PubMed ID: 29116623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables.
    Vo QN; Geradts J; Boudreau DA; Bravo JC; Schneider BG
    Hum Pathol; 2002 Dec; 33(12):1200-4. PubMed ID: 12514789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different roles for p16(INK) (4a) -Rb pathway and INK4a/ARF methylation between adenocarcinomas of gastric cardia and distal stomach.
    Xue L; Ouyang Q; Li J; Meng X; Li Y; Xing L; Wang J; Yan X; Zhang X
    J Gastroenterol Hepatol; 2014; 29(7):1418-26. PubMed ID: 25123601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological and molecular characteristics of gastric papillary adenocarcinoma.
    Arai T; Komatsu A; Kanazawa N; Nonaka K; Ishiwata T
    Pathol Int; 2023 Aug; 73(8):358-366. PubMed ID: 37341602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability.
    Abe H; Maeda D; Hino R; Otake Y; Isogai M; Ushiku AS; Matsusaka K; Kunita A; Ushiku T; Uozaki H; Tateishi Y; Hishima T; Iwasaki Y; Ishikawa S; Fukayama M
    Virchows Arch; 2012 Oct; 461(4):367-77. PubMed ID: 22915242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.